{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:55:52Z","timestamp":1791327352674,"version":"4.3.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T00:00:00Z","timestamp":1766793600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-15368-2","type":"journal-article","created":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T03:15:09Z","timestamp":1766805309000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Histone acetyltransferase KAT6A contributes to colon cancer malignant progression by inhibiting ferroptosis"],"prefix":"10.1186","volume":"26","author":[{"given":"Junyu","family":"Huo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongguang","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yugang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,27]]},"reference":[{"key":"15368_CR1","doi-asserted-by":"crossref","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","DOI":"10.3322\/caac.21834"},{"key":"15368_CR2","doi-asserted-by":"crossref","unstructured":"Ruan H, Leibowitz BJ, Zhang L. and J. Yu. Immunogenic cell death in colon cancer prevention and therapy. Mol Carcinog. 2020;59(7):783\u201393.","DOI":"10.1002\/mc.23183"},{"key":"15368_CR3","doi-asserted-by":"crossref","unstructured":"Arredondo J, Pastor E, Sim\u00f3 V et al. Neoadjuvant chemotherapy in locally advanced colon cancer: a systematic review. Tech Coloproctol.\u00a02020;24(10):1001\u201315.","DOI":"10.1007\/s10151-020-02289-4"},{"key":"15368_CR4","doi-asserted-by":"crossref","unstructured":"Auclin E, Zaanan A, Vernerey D et al. Subgroups and prognostication in stage III colon cancer: future perspectives for adjuvant therapy. Ann Oncol.\u00a02017;28(5):958\u201368.","DOI":"10.1093\/annonc\/mdx030"},{"key":"15368_CR5","unstructured":"Colon Cancer, Am Fam Physician. 2018;97(10):Online."},{"key":"15368_CR6","doi-asserted-by":"crossref","unstructured":"Lei G, Zhuang L, Gan B. Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer. 2022;22(7):381\u201396.","DOI":"10.1038\/s41568-022-00459-0"},{"key":"15368_CR7","doi-asserted-by":"crossref","unstructured":"Mou Y, Wang J, Wu J et al. Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J Hematol Oncol. 2019;12(1):34.","DOI":"10.1186\/s13045-019-0720-y"},{"key":"15368_CR8","doi-asserted-by":"crossref","unstructured":"Li D, Li Y. The interaction between ferroptosis and lipid metabolism in cancer. Signal Transduct Target Ther.\u00a02020;5(1):108.","DOI":"10.1038\/s41392-020-00216-5"},{"key":"15368_CR9","doi-asserted-by":"crossref","unstructured":"Koppula P, Zhuang L, Gan B. Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell.\u00a02021;12(8):599\u2013620.","DOI":"10.1007\/s13238-020-00789-5"},{"key":"15368_CR10","doi-asserted-by":"crossref","unstructured":"Liang C, Zhang X, Yang M, Dong X. Recent progress in ferroptosis inducers for cancer therapy. Adv Mater. 2019;31(51):e1904197.","DOI":"10.1002\/adma.201904197"},{"key":"15368_CR11","doi-asserted-by":"crossref","unstructured":"Hassannia B, Vandenabeele P, Vanden Berghe T. Targeting ferroptosis to iron out cancer. Cancer Cell.\u00a02019;35(6):830\u201349.","DOI":"10.1016\/j.ccell.2019.04.002"},{"key":"15368_CR12","doi-asserted-by":"crossref","unstructured":"Zhang C, Liu X, Jin S, Chen Y, Guo R. Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. Mol Cancer.\u00a02022;21(1):47.","DOI":"10.1186\/s12943-022-01530-y"},{"key":"15368_CR13","doi-asserted-by":"crossref","unstructured":"Baell JB, Leaver DJ, Hermans SJ et al. Inhibitors of histone acetyltransferases KAT6A\/B induce senescence and arrest tumour growth. Nature.\u00a02018;560(7717):253\u20137.","DOI":"10.1038\/s41586-018-0387-5"},{"key":"15368_CR14","doi-asserted-by":"crossref","unstructured":"Wiesel-Motiuk N, Assaraf YG. The key roles of the lysine acetyltransferases KAT6A and KAT6B in physiology and pathology. Drug Resist Updat.\u00a02020;53:100729.","DOI":"10.1016\/j.drup.2020.100729"},{"key":"15368_CR15","doi-asserted-by":"crossref","unstructured":"Yan F, Li J, Milosevic J et al. KAT6A and ENL form an epigenetic transcriptional control module to drive critical leukemogenic Gene-Expression programs. Cancer Discov. 2022;12(3):792\u2013811.","DOI":"10.1158\/2159-8290.CD-20-1459"},{"key":"15368_CR16","doi-asserted-by":"crossref","unstructured":"Saglam O, Tang Z, Tang G, Medeiros LJ, Toruner GA. KAT6A amplifications are associated with shorter progression-free survival and overall survival in patients with endometrial serous carcinoma. PLoS ONE. 2020;15(9):e0238477.","DOI":"10.1371\/journal.pone.0238477"},{"key":"15368_CR17","doi-asserted-by":"crossref","unstructured":"Partynska A, Piotrowska A, Pawelczyk K et al. The expression of histone acetyltransferase KAT6A in Non-small cell lung cancer. Anticancer Res. 2022;42(12):5731\u201341.","DOI":"10.21873\/anticanres.16080"},{"key":"15368_CR18","doi-asserted-by":"crossref","unstructured":"Su J, Wang X, Bai Y, Sun M, Yao Y, Duan Y. The role of MOZ\/KAT6A in hematological malignancies and advances in MOZ\/KAT6A inhibitors. Pharmacol Res.\u00a02021;174:105930.","DOI":"10.1016\/j.phrs.2021.105930"},{"key":"15368_CR19","doi-asserted-by":"crossref","unstructured":"Liu W, Zhan Z, Zhang M et al. KAT6A, a novel regulator of \u03b2-catenin, promotes tumorigenicity and chemoresistance in ovarian cancer by acetylating COP1. Theranostics.\u00a02021;11(13):6278\u201392.","DOI":"10.7150\/thno.57455"},{"key":"15368_CR20","doi-asserted-by":"crossref","unstructured":"Turner-Ivey B, Guest ST, Irish JC et al. KAT6A, a chromatin modifier from the 8p11-p12 amplicon is a candidate oncogene in luminal breast cancer. Neoplasia. 2014;16(8):644\u201355.","DOI":"10.1016\/j.neo.2014.07.007"},{"key":"15368_CR21","doi-asserted-by":"crossref","unstructured":"Yu B, Luo F, Sun B, et al. KAT6A acetylation of SMAD3 regulates Myeloid-Derived suppressor cell Recruitment, Metastasis, and immunotherapy in Triple-Negative breast cancer. Adv Sci (Weinh).\u00a02021;8(20):e2100014.","DOI":"10.1002\/advs.202100014"},{"key":"15368_CR22","doi-asserted-by":"crossref","unstructured":"Lv D, Jia F, Hou Y et al. Histone acetyltransferase KAT6A upregulates PI3K\/AKT signaling through TRIM24 binding. Cancer Res.\u00a02017;77(22):6190\u2013201.","DOI":"10.1158\/0008-5472.CAN-17-1388"},{"key":"15368_CR23","doi-asserted-by":"crossref","unstructured":"Jin Y, Yang R, Ding J et al. KAT6A is associated with Sorafenib resistance and contributes to progression of hepatocellular carcinoma by targeting YAP. Biochem Biophys Res Commun. 2021;585:185\u201390.","DOI":"10.1016\/j.bbrc.2021.09.009"},{"key":"15368_CR24","doi-asserted-by":"crossref","unstructured":"Seibt TM, Proneth B, Conrad M. Role of GPX4 in ferroptosis and its Pharmacological implication. Free Radic Biol Med. 2019;133:144\u201352.","DOI":"10.1016\/j.freeradbiomed.2018.09.014"},{"key":"15368_CR25","doi-asserted-by":"crossref","unstructured":"Hangauer MJ, Viswanathan VS, Ryan MJ et al. Drug-tolerant persister cancer cells are vulnerable to GPX4 Inhibition. Nature.\u00a02017;551(7679):247\u201350.","DOI":"10.1038\/nature24297"},{"key":"15368_CR26","doi-asserted-by":"crossref","unstructured":"Mao C, Liu X, Zhang Y et al. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. Nature.\u00a02021;593(7860):586\u201390.","DOI":"10.1038\/s41586-021-03539-7"},{"key":"15368_CR27","doi-asserted-by":"crossref","unstructured":"Yang WS, SriRamaratnam R, Welsch ME et al. Regulation of ferroptotic cancer cell death by GPX4. Cell.\u00a02014;156(1-2):317\u201331.","DOI":"10.1016\/j.cell.2013.12.010"},{"key":"15368_CR28","doi-asserted-by":"crossref","unstructured":"Ding Y, Chen X, Liu C et al. Identification of a small molecule as inducer of ferroptosis and apoptosis through ubiquitination of GPX4 in triple\u2002negative\u2002breast\u2002cancer cells. J Hematol Oncol. 2021;14(1):19.","DOI":"10.1186\/s13045-020-01016-8"},{"key":"15368_CR29","doi-asserted-by":"crossref","unstructured":"Ghoochani A, Hsu EC, Aslan M et al. Ferroptosis inducers are a novel therapeutic approach for advanced prostate cancer. Cancer Res.\u00a02021;81(6):1583\u201394.","DOI":"10.1158\/0008-5472.CAN-20-3477"},{"key":"15368_CR30","doi-asserted-by":"crossref","unstructured":"Schwab A, Rao Z, Zhang J et al. Zeb1 mediates EMT\/plasticity-associated ferroptosis sensitivity in cancer cells by regulating lipogenic enzyme expression and phospholipid composition. Nat Cell Biol. 2024;26(9):1470\u201381.","DOI":"10.1038\/s41556-024-01464-1"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-15368-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15368-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15368-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T12:33:58Z","timestamp":1769603638000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-025-15368-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,27]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15368"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-15368-2","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,27]]},"assertion":[{"value":"18 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Shandong Provincial Hospital Affiliated to Shandong First Medical University (No.KT2022-05-18-01). Informed consent was obtained from all participants in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"150"}}